Blastic-phase Chronic Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Blastic-phase Chronic Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-11-02Clinical Trial Update: Phase I/II Study of Nilotinib/Ruxolitinb Therapy for TKI Resistant Ph-Leukemia [Phase 1, Phase 2]
Phase I/II study evaluating nilotinib combined with ruxolitinib in TKI-resistant Philadelphia chromosome-positive leukemias; trial status co…
-
CLINICAL_TRIALS trial_result · 2017-12-08Clinical Trial Update: Rasburicase and Allopurinol in Treating Patients With Hematologic Malignancies [Phase 2]
Phase 2 trial evaluating rasburicase and allopurinol in adults with hematologic malignancies; the study was terminated with results posted i…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Imatinib Mesylate and Decitabine in Treating Patients With Chronic Myelogenous Leukemia [Phase 2]
A Phase 2 clinical trial evaluated the combination of imatinib mesylate and decitabine for chronic myeloid leukemia, including accelerated- …
-
CLINICAL_TRIALS trial_result · 2013-01-09Clinical Trial Update: Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid Cancer [Phase 1]
Phase 1 study assessing the safety of adding sargramostim (GM-CSF) to chemotherapy in patients with refractory myeloid cancers; the trial ha…